Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study).
Jpn J Clin Oncol
; 52(11): 1345-1352, 2022 Nov 03.
Article
in En
| MEDLINE
| ID: mdl-35920793
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
Type of study:
Observational_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Jpn J Clin Oncol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: